Xiu‐Fang Du

458 citations
11 papers · 88 indexed · h-index 6
Topics
Brucella: diagnosis, epidemiology, treatment (4 papers)RNA modifications and cancer (3 papers)Cancer-related molecular mechanisms research (3 papers)
Journals
SHILAP Revista de lepidopterologíaBMC CancerBMC Infectious Diseases
Partner nations
ChinaAustralia

In The Last Decade

Xiu‐Fang Du

9 papers receiving 86 citations

Peers

Xiu‐Fang Du
Comparison fields: 5 of 36
  • Molecular Biology 40
  • Cancer Research 33
  • Immunology 23
  • Small Animals 17
  • Pulmonary and Respiratory Medicine 16
Replace Muhammad Azhar with:
Muhammad Azhar Pakistan
Mohammad Masood India
Manar Ata Saudi Arabia
Ying‐Cing Lin United States
Burair Alsaihati Saudi Arabia
Zhihui Feng China
Yoshiko Kaku Japan
Dipanwita Roy Choudhury United States
Pia‐Katharina Larsen Germany
Céline Le Béguec France
Xiu‐Fang Du relative to Muhammad Azhar Pakistan Muhammad Azhar's profile →
Citations per field
00.5×2.9×
Muhammad Azhar · 1×
Citations per year

Countries citing papers authored by Xiu‐Fang Du

Since Specialization
Citations

This map shows the geographic impact of Xiu‐Fang Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiu‐Fang Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiu‐Fang Du more than expected).

Fields of papers citing papers by Xiu‐Fang Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiu‐Fang Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiu‐Fang Du. The network helps show where Xiu‐Fang Du may publish in the future.

Co-authorship network of co-authors of Xiu‐Fang Du

This figure shows the co-authorship network connecting the top 25 collaborators of Xiu‐Fang Du. A scholar is included among the top collaborators of Xiu‐Fang Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiu‐Fang Du. Xiu‐Fang Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 0
2 12
3 0
4 3
5 5
6 31
7 7
8 11
9 11
10 3
11 5

About Xiu‐Fang Du

Xiu‐Fang Du is a scholar working on Small Animals, Cancer Research and Immunology, having authored 11 papers that have together received 88 indexed citations. Recurring topics across this work include Brucella: diagnosis, epidemiology, treatment (4 papers), RNA modifications and cancer (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Small Animals (17 citations), Cancer Research (33 citations) and Immunology (23 citations). Xiu‐Fang Du has collaborated with scholars based in China and Australia. Frequent co-authors include Gang Chen, Rong‐Quan He, Jian‐Di Li, Zhi‐Guang Huang, Linjie Yang, Limin Liu, Hong Yang, Siyuan Yang, Linghang Wang and Yi‐Wu Dang. Their work appears in journals such as SHILAP Revista de lepidopterología, BMC Cancer and BMC Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026